Bandim Health Project
Guinea-Bissau
- Country
- Guinea-Bissau
- Ownership
- Private
- Established
- 1978-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.bandim.org
The Non-Specific Immunological Effects of Providing Oral Polio Vaccine to Seniors in Guinea-Bissau
Phase 4
- Conditions
- Vaccine Reaction
- Interventions
- Other: PlaceboBiological: Oral polio vaccine
- First Posted Date
- 2024-02-20
- Last Posted Date
- 2024-02-20
- Lead Sponsor
- Bandim Health Project
- Target Recruit Count
- 80
- Registration Number
- NCT06266754
- Locations
- 🇬🇼
Bandim Health Project, Apartado 861, Bissau, Guinea-Bissau
Diabetes Diagnosis, Management, Prevention and Education in Guinea-Bissau
Phase 4
Recruiting
- Conditions
- BCG Vaccination ReactionDiabetes Mellitus
- Interventions
- Biological: BCG vaccine (two doses, 4 weeks apart)Biological: Saline placebo (Two doses, 4 weeks apart)
- First Posted Date
- 2022-10-24
- Last Posted Date
- 2024-01-22
- Lead Sponsor
- Bandim Health Project
- Target Recruit Count
- 200
- Registration Number
- NCT05591339
- Locations
- 🇬🇼
Bandim Health Project, Bissau, Guinea-Bissau
Trial to Compare BCG-Bulgaria and BCG-Denmark
Phase 4
Recruiting
- Conditions
- Morbidity;NewbornMorbidity;InfantNon-specific Effects of VaccinesDeath; NeonatalDeath, Infant
- Interventions
- Biological: BCG-DenmarkBiological: BCG-Bulgaria
- First Posted Date
- 2022-05-31
- Last Posted Date
- 2024-01-22
- Lead Sponsor
- Bandim Health Project
- Target Recruit Count
- 15000
- Registration Number
- NCT05397678
- Locations
- 🇬🇼
Bandim Health Project, Bissau, Guinea-Bissau
Effectiveness and Safety of Artemether + Lumefantrine and Dihydroartemisinin + Piperaquine for Treating Malaria
Phase 4
Completed
- Conditions
- EffectivenessMalaria
- Interventions
- Drug: Dihydroartemisinin-piperaquine 160 mg/20 mg Oral TabletDrug: Artemether-Lumefantrine 20 Mg-120 Mg Oral Tablet
- First Posted Date
- 2021-05-24
- Last Posted Date
- 2022-04-12
- Lead Sponsor
- Bandim Health Project
- Target Recruit Count
- 474
- Registration Number
- NCT04897919
- Locations
- 🇬🇼
Bandim Health Centre, Bissau, Bissau Codex, Guinea-Bissau
Measles and BCG Vaccines for Mother and Child
Phase 4
Recruiting
- Conditions
- Vaccine Preventable DiseaseMeaslesBCG Vaccination ReactionMother-Infant Interaction
- Interventions
- Other: PlaceboBiological: Measles vaccineBiological: BCG vaccine
- First Posted Date
- 2021-05-24
- Last Posted Date
- 2024-01-19
- Lead Sponsor
- Bandim Health Project
- Target Recruit Count
- 2400
- Registration Number
- NCT04899765
- Locations
- 🇬🇼
Bandim Health Project, Bissau, Bissau Codex, Guinea-Bissau
Can BCG Vaccination at First Health-facility Contact Reduce Early Infant Mortality?
Phase 4
Recruiting
- Conditions
- Infant MortalityBCG
- Interventions
- First Posted Date
- 2020-12-08
- Last Posted Date
- 2024-01-22
- Lead Sponsor
- Bandim Health Project
- Target Recruit Count
- 22800
- Registration Number
- NCT04658680
- Locations
- 🇬🇼
Bandim Health Project, Bissau, Guinea-Bissau
Using BCG to Protect Senior Citizens During the COVID-19 Pandemic
Phase 3
Completed
- Conditions
- Non-specific Effects of VaccinesImmunosenescenceHeterologous ImmunityMorbidityCovid19Vaccine Preventable Disease
- Interventions
- Biological: SalineBiological: BCG-Denmark
- First Posted Date
- 2020-09-09
- Last Posted Date
- 2024-08-22
- Lead Sponsor
- Bandim Health Project
- Target Recruit Count
- 1700
- Registration Number
- NCT04542330
- Locations
- 🇩🇰
Seniorhuset, Odense, Denmark
Locally Produced Cloth Face Mask and COVID-19 Like Illness Prevention
Not Applicable
- Conditions
- COVID-19Respiratory Illness
- Interventions
- Other: Certified cloth face mask plus preventive informationBehavioral: Preventive information
- First Posted Date
- 2020-07-15
- Last Posted Date
- 2021-10-13
- Lead Sponsor
- Bandim Health Project
- Target Recruit Count
- 40000
- Registration Number
- NCT04471766
- Locations
- 🇬🇼
Bandim Health Project, Bissau, Bissau Codex, Guinea-Bissau
OPV as Potential Protection Against COVID-19
Phase 4
- Conditions
- MortalityMorbidityCOVIDPoliovirus Vaccine, OralNon-Specific Effects of Vaccines
- Interventions
- Biological: oral polio vaccine + informationBehavioral: Information
- First Posted Date
- 2020-06-24
- Last Posted Date
- 2022-03-18
- Lead Sponsor
- Bandim Health Project
- Target Recruit Count
- 3400
- Registration Number
- NCT04445428
- Locations
- 🇬🇼
Bandim Health Project, Bissau, Guinea-Bissau
Trial to Compare Two Strains of BCG
Phase 4
Completed
- Conditions
- Death, InfantMorbidity;Infant
- Interventions
- Biological: BCG-JapanBiological: BCG-Russia
- First Posted Date
- 2020-05-12
- Last Posted Date
- 2024-01-22
- Lead Sponsor
- Bandim Health Project
- Target Recruit Count
- 16390
- Registration Number
- NCT04383925
- Locations
- 🇬🇼
Bandim Health Project, Bissau, Guinea-Bissau
© Copyright 2025. All Rights Reserved by MedPath